Chronic Pruritus Clinical Trial
Official title:
Study of Kids Itch Severity (SKIS): "Validation and Mobilization of Pediatric Pruritus Outcome Instruments"
This purpose of this study is to validate two measures of chronic itching in kids: itch severity (ItchyQuant) and the impact on their quality of life (ItchyQoL).
There are many diseases that affect children where the primary symptom is pruritus. This study aims to validate an age appropriate pediatric version of the ItchyQoL, a pruritus-specific quality of life instrument, and the ItchyQuant, a self-reported itch severity scale, to better understand how pruritus affects the pediatric population. These instruments will comprehensively capture the severity and impact of pruritus in children. The physicians want to explore the opportunity to integrate patient-reported outcome measures (PROM) as a patient-reported tool in the ambulatory setting. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05038982 -
Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin
|
Phase 2 | |
Completed |
NCT01951274 -
VPD-737 for Treatment of Chronic Pruritus
|
Phase 2 | |
Completed |
NCT04949893 -
Causes of Chronic Pruritus
|
||
Completed |
NCT03751111 -
Treatment of Chronic Itch in Patients Under Arsenic Exposure With Sublingual Naloxone
|
Phase 1/Phase 2 | |
Completed |
NCT04693195 -
A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis
|
Phase 2 | |
Not yet recruiting |
NCT05678309 -
Establishment of a Patient Library in Patients With Pruritus Sine Materia
|